Effect of extracorporeal carbon dioxide removal on respiratory quotient measured by indirect calorimetry: Unravelling the mystery.


Journal

Experimental physiology
ISSN: 1469-445X
Titre abrégé: Exp Physiol
Pays: England
ID NLM: 9002940

Informations de publication

Date de publication:
05 2022
Historique:
received: 17 12 2021
accepted: 09 03 2022
pubmed: 15 3 2022
medline: 3 5 2022
entrez: 14 3 2022
Statut: ppublish

Résumé

What is the main observation in this case? Several studies have reported progressive hypoxaemia once extracorporeal carbon dioxide removal is started in patients with hypercapnic respiratory failure, possibly attributable to an altered respiratory quotient. What insights does it reveal? In this quality control report, we show that the respiratory quotient exhibits only minimal alteration when extracorporeal carbon dioxide removal is started and assume that the progressive hypoxaemia is attributable to an increase in intrapulmonary shunt. The use of extracorporeal carbon dioxide removal (ECCO

Identifiants

pubmed: 35286745
doi: 10.1113/EP090282
doi:

Substances chimiques

Carbon Dioxide 142M471B3J
Oxygen S88TT14065

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

424-428

Informations de copyright

© 2022 The Authors. Experimental Physiology © 2022 The Physiological Society.

Références

Braune, S., Sieweke, A., Brettner, F., Staudinger, T., Joannidis, M., Verbrugge, S., Frings, D., Nierhaus, A., Wegscheider, K., & Kluge, S. (2016). The feasibility and safety of extracorporeal carbon dioxide removal to avoid intubation in patients with COPD unresponsive to noninvasive ventilation for acute hypercapnic respiratory failure (ECLAIR study): Multicentre case-control study. Intensive Care Medicine, 42(9), 1437-1444. https://doi.org/10.1007/s00134-016-4452-y
Chen, Y., Wang, S., Huang, J., Fu, Y., Wen, J., Zhou, C., Fu, Y., & Liu, L. (2021). Application of extracorporeal carbon dioxide removal combined with continuous blood purification therapy in ARDS with hypercapnia in patients with critical COVID-19. Clinical Hemorheology and Microcirculation, 78(2), 199-207. https://doi.org/10.3233/CH-201080
Combes, A., Fanelli, V., Pham, T., & Ranieri, V. M. (2019). Feasibility and safety of extracorporeal CO2 removal to enhance protective ventilation in acute respiratory distress syndrome: The SUPERNOVA study. Intensive Care Medicine, 45(5), 592-600. https://doi.org/10.1007/s00134-019-05567-4
Del Sorbo, L., Fan, E., Nava, S., & Ranieri, V. M. (2016). ECCO2R in COPD exacerbation only for the right patients and with the right strategy. Intensive Care Medicine, 42(11), 1830-1831. https://doi.org/10.1007/s00134-016-4493-2
Diehl, J.-L., Mercat, A., & Pesenti, A. (2019). Understanding hypoxemia on ECCO2R: Back to the alveolar gas equation. Intensive Care Medicine, 45(2), 255-256. https://doi.org/10.1007/s00134-018-5409-0
Diehl, J.-L., Piquilloud, L., Richard, J.-C. M., Mancebo, J., & Mercat, A. (2016). Effects of extracorporeal carbon dioxide removal on work of breathing in patients with chronic obstructive pulmonary disease. Intensive Care Medicine, 42(5), 951-952. https://doi.org/10.1007/s00134-015-4166-6
Gacitúa, I., Frías, A., Sanhueza, M. E., Bustamante, S., Cornejo, R., Salas, A., Guajardo, X., Torres, K., Figueroa Canales, E., Tobar, E., Navarro, R., & Romero, C. (2021). Extracorporeal CO2 removal and renal replacement therapy in acute severe respiratory failure in COVID-19 pneumonia: Case report. Seminars in Dialysis, 34(3), 257-262. https://doi.org/10.1111/sdi.12980
Gattinoni, L., Kolobow, T., Tomlinson, T., White, D., & Pierce, J. (1978). Control of intermittent positive pressure breathing (IPPB) by extracorporeal removal of carbon dioxide. British Journal of Anaesthesia, 50(8), 753-758. https://doi.org/10.1093/bja/50.8.753
Morelli, A., Del Sorbo, L., Pesenti, A., Ranieri, V. M., & Fan, E. (2017). Extracorporeal carbon dioxide removal (ECCO2R) in patients with acute respiratory failure. Intensive Care Medicine, 43(4), 519-530. https://doi.org/10.1007/s00134-016-4673-0
Saavedra-Romero, R., Paz, F., Litell, J. M., Weinkauf, J., Benson, C. C., Tindell, L., & Williams, K. (2021). Treatment of severe hypercapnic respiratory failure caused by SARS-CoV-2 lung injury with ECCO2R using the hemolung respiratory assist system. Case Reports in Critical Care, 2021, 9958343. https://doi.org/10.1155/2021/9958343

Auteurs

Idris E Ghijselings (IE)

Department of Intensive Care, University Hospital of Brussels, Brussels, Belgium.

Brecht Bockstael (B)

Department of Anesthesia, University Hospital of Brussels, Brussels, Belgium.

Elisabeth De Waele (E)

Department of Intensive Care, University Hospital of Brussels, Brussels, Belgium.
Department of Nutrition, University Hospital of Brussels, Brussels, Belgium.

Joop Jonckheer (J)

Department of Intensive Care, University Hospital of Brussels, Brussels, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH